Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study

Background: Older patients with cancer are at a higher risk of invasive infections. Vaccination is an effective approach to decrease the mortality and morbidity associated with infections. Objectives: Our primary objective was to evaluate the proportion of older patients with cancer who had received...

Full description

Bibliographic Details
Main Authors: Tabitha M Sabu, Vanita Noronha, Abhijith R Rao, Anita Kumar, Shreya Gattani, Anant Ramaswamy, Anupa Pillai, Ratan Dhekale, Renita Castelino, Sharath Kumar, Arshiya Sehgal, Pallavi Rana, Vikram Gota, Rajendra Badwe, Kumar Prabhash
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Cancer Research, Statistics, and Treatment
Subjects:
Online Access:http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=1;spage=52;epage=61;aulast=Sabu
_version_ 1797824449463975936
author Tabitha M Sabu
Vanita Noronha
Abhijith R Rao
Anita Kumar
Shreya Gattani
Anant Ramaswamy
Anupa Pillai
Ratan Dhekale
Renita Castelino
Sharath Kumar
Arshiya Sehgal
Pallavi Rana
Vikram Gota
Rajendra Badwe
Kumar Prabhash
author_facet Tabitha M Sabu
Vanita Noronha
Abhijith R Rao
Anita Kumar
Shreya Gattani
Anant Ramaswamy
Anupa Pillai
Ratan Dhekale
Renita Castelino
Sharath Kumar
Arshiya Sehgal
Pallavi Rana
Vikram Gota
Rajendra Badwe
Kumar Prabhash
author_sort Tabitha M Sabu
collection DOAJ
description Background: Older patients with cancer are at a higher risk of invasive infections. Vaccination is an effective approach to decrease the mortality and morbidity associated with infections. Objectives: Our primary objective was to evaluate the proportion of older patients with cancer who had received routine vaccinations against pneumococcal, influenza, and coronavirus disease 2019 (COVID-19). Our secondary objective was to identify the factors associated with vaccine uptake such as age, sex, education, marital status, comorbidities, and place of residence. Materials and Methods: This cross-sectional observational study was conducted in the geriatric oncology outpatient clinic of the Department of Medical Oncology at the Tata Memorial Hospital, a tertiary care cancer hospital in Mumbai, India, from February 2020 to January 2023. We included all patients aged ≥60 years who were evaluated in the geriatric oncology clinic during the study period and for whom the immunization details were available. The uptake of COVID-19 vaccine was calculated from March 2021 onwards, which was when the COVID-19 vaccine became available to patients aged ≥60 years in India. Results: We enrolled 1762 patients; 1342 (76.2%) were male. The mean age was 68.4 (SD, 5.8) years; 795 (45%) patients were from the west zone of India. Only 12 (0.68%) patients had received the pneumococcal vaccine, and 13 (0.7%) had received the influenza vaccine. At least one dose of the COVID-19 vaccine had been taken by 1302 of 1562 patients (83.3%). On univariate logistic regression, education, marital status, geographic zone of residence, and primary tumor site were correlated with the uptake of COVID-19 vaccine. Factors associated with a greater COVID-19 vaccine uptake included education (up to Std 10 and higher vs. less than Std 10: Odds Ratio [OR], 1.46; 95% confidence interval [CI], 1.07-1.99; P = 0.018, and illiterate vs. less than Std 10: OR, 0.70; 95% CI, 0.50-0.99; P = 0.041), marital status (unmarried vs. married: OR, 0.27; 95% CI, 0.08-1.08; P = 0.046, and widow/widower vs. married: OR, 0.67; 95% CI, 0.48-0.94; P = 0.017), lung and gastrointestinal vs. head-and-neck primary tumors (lung cancer vs. head-and-neck cancer: OR, 1.60; 95% CI, 1.02–2.47; P = 0.038, and gastrointestinal vs .head-and-neck cancer: OR, 2.18; 95% CI, 1.37-3.42; P < 0.001), and place of residence (west zone vs. central India: OR, 0.34; 95% CI, 0.13-0.75; P = 0.015). Conclusion: Fewer than 1 in 100 older Indian patients with cancer receive routine immunization with influenza and pneumococcal vaccines. Hearteningly, the uptake of COVID-19 vaccination in older Indian patients with cancer is over 80%, possibly due to the global recognition of its importance during the pandemic. Similar measures as those used to increase the uptake of COVID-19 vaccines during the pandemic may be beneficial to increase the uptake of routine vaccinations (Clinical Trials Registry, India: CTRI/2020/04/024675).
first_indexed 2024-03-13T10:39:08Z
format Article
id doaj.art-89e3eb3c233346268505e677a9d550f0
institution Directory Open Access Journal
issn 2590-3233
2590-3225
language English
last_indexed 2024-03-13T10:39:08Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Cancer Research, Statistics, and Treatment
spelling doaj.art-89e3eb3c233346268505e677a9d550f02023-05-18T05:04:23ZengWolters Kluwer Medknow PublicationsCancer Research, Statistics, and Treatment2590-32332590-32252023-01-0161526110.4103/crst.crst_29_23Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational studyTabitha M SabuVanita NoronhaAbhijith R RaoAnita KumarShreya GattaniAnant RamaswamyAnupa PillaiRatan DhekaleRenita CastelinoSharath KumarArshiya SehgalPallavi RanaVikram GotaRajendra BadweKumar PrabhashBackground: Older patients with cancer are at a higher risk of invasive infections. Vaccination is an effective approach to decrease the mortality and morbidity associated with infections. Objectives: Our primary objective was to evaluate the proportion of older patients with cancer who had received routine vaccinations against pneumococcal, influenza, and coronavirus disease 2019 (COVID-19). Our secondary objective was to identify the factors associated with vaccine uptake such as age, sex, education, marital status, comorbidities, and place of residence. Materials and Methods: This cross-sectional observational study was conducted in the geriatric oncology outpatient clinic of the Department of Medical Oncology at the Tata Memorial Hospital, a tertiary care cancer hospital in Mumbai, India, from February 2020 to January 2023. We included all patients aged ≥60 years who were evaluated in the geriatric oncology clinic during the study period and for whom the immunization details were available. The uptake of COVID-19 vaccine was calculated from March 2021 onwards, which was when the COVID-19 vaccine became available to patients aged ≥60 years in India. Results: We enrolled 1762 patients; 1342 (76.2%) were male. The mean age was 68.4 (SD, 5.8) years; 795 (45%) patients were from the west zone of India. Only 12 (0.68%) patients had received the pneumococcal vaccine, and 13 (0.7%) had received the influenza vaccine. At least one dose of the COVID-19 vaccine had been taken by 1302 of 1562 patients (83.3%). On univariate logistic regression, education, marital status, geographic zone of residence, and primary tumor site were correlated with the uptake of COVID-19 vaccine. Factors associated with a greater COVID-19 vaccine uptake included education (up to Std 10 and higher vs. less than Std 10: Odds Ratio [OR], 1.46; 95% confidence interval [CI], 1.07-1.99; P = 0.018, and illiterate vs. less than Std 10: OR, 0.70; 95% CI, 0.50-0.99; P = 0.041), marital status (unmarried vs. married: OR, 0.27; 95% CI, 0.08-1.08; P = 0.046, and widow/widower vs. married: OR, 0.67; 95% CI, 0.48-0.94; P = 0.017), lung and gastrointestinal vs. head-and-neck primary tumors (lung cancer vs. head-and-neck cancer: OR, 1.60; 95% CI, 1.02–2.47; P = 0.038, and gastrointestinal vs .head-and-neck cancer: OR, 2.18; 95% CI, 1.37-3.42; P < 0.001), and place of residence (west zone vs. central India: OR, 0.34; 95% CI, 0.13-0.75; P = 0.015). Conclusion: Fewer than 1 in 100 older Indian patients with cancer receive routine immunization with influenza and pneumococcal vaccines. Hearteningly, the uptake of COVID-19 vaccination in older Indian patients with cancer is over 80%, possibly due to the global recognition of its importance during the pandemic. Similar measures as those used to increase the uptake of COVID-19 vaccines during the pandemic may be beneficial to increase the uptake of routine vaccinations (Clinical Trials Registry, India: CTRI/2020/04/024675).http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=1;spage=52;epage=61;aulast=Sabugeriatricmorbiditymortalityvaccination
spellingShingle Tabitha M Sabu
Vanita Noronha
Abhijith R Rao
Anita Kumar
Shreya Gattani
Anant Ramaswamy
Anupa Pillai
Ratan Dhekale
Renita Castelino
Sharath Kumar
Arshiya Sehgal
Pallavi Rana
Vikram Gota
Rajendra Badwe
Kumar Prabhash
Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study
Cancer Research, Statistics, and Treatment
geriatric
morbidity
mortality
vaccination
title Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study
title_full Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study
title_fullStr Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study
title_full_unstemmed Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study
title_short Uptake of vaccination in older Indian patients with cancer: A cross-sectional observational study
title_sort uptake of vaccination in older indian patients with cancer a cross sectional observational study
topic geriatric
morbidity
mortality
vaccination
url http://www.crstonline.com/article.asp?issn=2590-3233;year=2023;volume=6;issue=1;spage=52;epage=61;aulast=Sabu
work_keys_str_mv AT tabithamsabu uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT vanitanoronha uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT abhijithrrao uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT anitakumar uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT shreyagattani uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT anantramaswamy uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT anupapillai uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT ratandhekale uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT renitacastelino uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT sharathkumar uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT arshiyasehgal uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT pallavirana uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT vikramgota uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT rajendrabadwe uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy
AT kumarprabhash uptakeofvaccinationinolderindianpatientswithcanceracrosssectionalobservationalstudy